logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Masahiko Hibi

This inventor holds 14 USPTO granted patents. Top assignees: University of California, Other. Active years: 1996-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiko Hibi. Retrieved from https://idiyas.com/inventor/masahiko-hibi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 64.3

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 104(Granted Patents)


Location History:

  • Hyogo, JP (2004 - 2005)
  • San Diego, CA (US) (1996 - 2008)

Company Filing History:

goldMedal13 out of 16,025 
 
University of California
 patents
silverMedal1 out of 834,513 
Other
 patents

Years Active: 1996-2008

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7468426 - Oncoprotein protein kinase antibody kit (2008-12-23),
2. 6863888 - Oncoprotein protein kinase (2005-03-08),
3. 6846644 - Oncoprotein protein kinase (2005-01-25),
4. 6706509 - Oncoprotein protein kinase (2004-03-16),
5. 6610505 - Oncoprotein protein kinase (2003-08-26),
6. 6514745 - Oncoprotein protein kinase (2003-02-04),
7. 6342595 - Oncoprotein protein kinase (2002-01-29),
8. 6193965 - Oncoprotein kinase (2001-02-27),
9. 6001584 - Oncoprotein protein kinase (1999-12-14),
10. 5837244 - Oncoprotein protein kinase (1998-11-17),
11. 5804399 - Oncoprotein protein kinase (1998-09-08),
12. 5605808 - Oncoprotein protein kinase (1997-02-25),
13. 5593884 - Oncoprotein protein kinase (1997-01-14),
14. 5534426 - Oncoprotein protein kinase (1996-07-09),

Title: Masahiko Hibi: Innovator in Oncoprotein Research

Introduction

Masahiko Hibi is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of oncoprotein research. He holds a total of 14 patents, showcasing his innovative work in the development of antibody kits and polypeptides that play a crucial role in cancer research.

Latest Patents

Hibi's latest patents include the Oncoprotein protein kinase antibody kit, which features an isolated polypeptide (JNK) characterized by a molecular weight of 46 kD, as determined by reducing SDS-PAGE. This polypeptide exhibits serine and threonine kinase activity, phosphorylating the c-Jun N-terminal activation domain and polynucleotide sequences. The method of detection of JNK is also provided, highlighting its role in affecting gene expression from AP-1 sites. Another notable patent is the Oncoprotein protein kinase, which shares similar characteristics and functions as the aforementioned antibody kit.

Career Highlights

Throughout his career, Masahiko Hibi has worked with esteemed institutions, including the University of California. His research has significantly advanced the understanding of oncoproteins and their implications in cancer biology.

Collaborations

Hibi has collaborated with notable colleagues such as Michael Karin and Anning Lin, contributing to a rich exchange of ideas and research findings in the field of oncoprotein studies.

Conclusion

Masahiko Hibi's innovative work in oncoprotein research has made a lasting impact on cancer studies, and his patents continue to influence the scientific community. His contributions are vital for advancing our understanding of cancer mechanisms and potential therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…